Canada markets closed

Poseida Therapeutics, Inc. (PSTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.6450-0.0650 (-2.40%)
At close: 04:00PM EDT
2.6500 +0.01 (+0.19%)
After hours: 06:52PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 256.38M
Enterprise Value 129.60M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)3.69
Price/Book (mrq)2.47
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.46
52-Week Change 3-10.34%
S&P500 52-Week Change 326.27%
52 Week High 34.2700
52 Week Low 31.5400
50-Day Moving Average 32.8729
200-Day Moving Average 32.7167

Share Statistics

Avg Vol (3 month) 3707.37k
Avg Vol (10 day) 3772.82k
Shares Outstanding 596.93M
Implied Shares Outstanding 696.93M
Float 863.98M
% Held by Insiders 127.67%
% Held by Institutions 147.70%
Shares Short (Apr 30, 2024) 46.04M
Short Ratio (Apr 30, 2024) 411.48
Short % of Float (Apr 30, 2024) 48.63%
Short % of Shares Outstanding (Apr 30, 2024) 46.24%
Shares Short (prior month Mar 28, 2024) 44.12M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -190.76%
Operating Margin (ttm)-103.66%

Management Effectiveness

Return on Assets (ttm)-25.87%
Return on Equity (ttm)-84.75%

Income Statement

Revenue (ttm)64.7M
Revenue Per Share (ttm)0.72
Quarterly Revenue Growth (yoy)148.70%
Gross Profit (ttm)N/A
EBITDA -123.89M
Net Income Avi to Common (ttm)-123.43M
Diluted EPS (ttm)-1.3700
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)212.2M
Total Cash Per Share (mrq)2.2
Total Debt (mrq)85.42M
Total Debt/Equity (mrq)82.37%
Current Ratio (mrq)3.18
Book Value Per Share (mrq)1.08

Cash Flow Statement

Operating Cash Flow (ttm)-92.17M
Levered Free Cash Flow (ttm)-40.72M